Indication
Stage IVB Primary Peritoneal Cancer AJCC v8
7 clinical trials
7 products
5 drugs
Clinical trial
Phase I/Ib Study Evaluating Safety and Efficacy of PRGN-3005 UltraCAR-T® (Autologous CAR T Cells) in Advanced Stage Platinum Resistant Ovarian Cancer PatientsStatus: Recruiting, Estimated PCD: 2024-12-15
Product
PRGN-3005Clinical trial
A Phase I/IIa Safety and Immunologic Efficacy Trial of Intraperitoneal Induction of CTLs Combined With Alpha-Dendritic Cell Vaccine for Primary Ovarian CancerStatus: Withdrawn, Estimated PCD: 2025-12-01
Clinical trial
Phase I Study of Talazoparib in Combination With Radiation Therapy for Locally Recurrent Gynecologic CancersStatus: Recruiting, Estimated PCD: 2024-10-01
Product
TalazoparibProduct
IpilimumabClinical trial
Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic CancersStatus: Active (not recruiting), Estimated PCD: 2025-04-30
Drug
T-VECClinical trial
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxStatus: Recruiting, Estimated PCD: 2026-09-01
Drug
AtezolizumabProduct
CabozantinibDrug
AbraxaneClinical trial
NOW: Neoadjuvant Olaparib Window Trial in Newly Diagnosed BRCA-Mutant Ovarian CancerStatus: Active (not recruiting), Estimated PCD: 2024-03-22
Drug
CisplatinProduct
OlaparibClinical trial
Laparoscopic Cytoreduction After Neoadjuvant ChemotherapyStatus: Recruiting, Estimated PCD: 2028-12-31
Drug
AN0025